Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantati

来源 :国际肝胆胰疾病杂志:英文版 | 被引量 : 0次 | 上传用户:Lyre_00
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:Liver transplantation(LT)is an effective therapy for end-stage hepatitis B virus(HBV)infection. Recurrence of HBV is one of the frequent complications.In the present study,we investigated whether human leukocyte antigen(HLA)matching influences
其他文献
BACKGROUND: Xanthogranulomatous cholecystitis (XGC) is a destructive inflammatory disease of the gallbladder that can mimic gallbladder carcinoma. METHODS: We p
BACKGROUND:Mesenchymal stem cells(MSCs)and fibro-blasts have intimate relationships,and the phenotypic homology between fibroblasts and MSCs has been recently d
BACKGROUND:Hepatic fibrosis is a necessary step in the development of hepatic cirrhosis.In this study we used lentiviral vector-mediated transfection technology
BACKGROUND:As a radical cure for post-hepatitis B virus (HBV)-related liver cirrhosis and hepatocellular carcinoma,liver transplantation has been applied in man
BACKGROUND: Most patients waiting for liver transplantation have end-stage liver diseases with malnutrition, which is prone to induce intestinal barrier dysfunc
BACKGROUND:A reliable model of fulminant liver failure (FLF) is urgently required in this research field.This study aimed to develop a murine FLF model.METHODS:
BACKGROUND:Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an uncommon subtype of primary hepatic carcinoma,and its prognosis is poor.This
BACKGROUND: Donor safety has always been a major concern and potential risk to the donor must be balanced against recipient benefit. However, lack of a standard
BACKGROUND:Cirrhosis is associated with several extrahepatic manifestations including portopulmonary hypertension (PPHT).Recent data suggest that endothelins (E
BACKGROUND:YKL-40 is a new biomarker with diagnostic value in many different cancers.Whether it may serve as a biomarker for hepatocellular carcinoma (HCC) is s